Finally, Barclays PLC increased its holdings in OraSure Technologies by 22.0% during the 3rd quarter.

Source: https://www.etfdailynews.com/2023/06/21/etf-managers-group-llc-decreases-stock-holdings-in-orasure-technologies-inc-nasdaqosur/

On average, sell-side analysts predict that OraSure Technologies, Inc. will post 0.62 EPS for the current year.

Source: https://www.americanbankingnews.com/2023/10/18/dekabank-deutsche-girozentrale-buys-new-shares-in-orasure-technologies-inc-nasdaqosur.html

OraSure Technologies, Inc, together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally.

Source: https://www.etfdailynews.com/2023/01/15/333358-shares-in-orasure-technologies-inc-nasdaqosur-purchased-by-assenagon-asset-management-s-a/

State Street Corp lifted its holdings in OraSure Technologies by 1.9% in the 2nd quarter.

Source: https://www.etfdailynews.com/2023/01/15/333358-shares-in-orasure-technologies-inc-nasdaqosur-purchased-by-assenagon-asset-management-s-a/